Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 2/20 | 0.36 |
| ▸ | BTK | Q06187 | 1/20 | 0.33 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.31 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.30 |
| ▸ | BRD2 | P25440 | 1/20 | 0.30 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31029982 | 1.00 | CRBN (0.36) | CRBNBTKMAP4K1DDB1BRD4 | |
| SCHEMBL25833437 | 0.91 | CRBN (0.39) | CRBNDDB1 | |
| SCHEMBL31188107 | 0.91 | CRBN (0.39) | CRBNDDB1 | |
| SCHEMBL25833443 | 0.91 | CRBN (0.35) | CRBNBTKMAP4K1DDB1 | |
| SCHEMBL31188137 | 0.91 | CRBN (0.35) | CRBNBTKMAP4K1DDB1 | |
| SCHEMBL25833434 | 0.88 | CRBN (0.38) | CRBNDDB1 | |
| SCHEMBL31188146 | 0.88 | CRBN (0.38) | CRBNDDB1 | |
| SCHEMBL21196586 | 0.80 | CRBN (0.46) | CRBNDDB1 | |
| SCHEMBL25833431 | 0.80 | CRBN (0.46) | CRBNDDB1 | |
| SCHEMBL31540198 | 0.80 | DDB1 (0.40) | CRBNDDB1BRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116981675-A | Degradation of Bruton's Tyrosine Kinase (BTK) by conjugation of BTK inhibitors to E3 ligase ligands and methods of use | 百济神州有限公司 | 2023-10-31 | — | — | CN | disclosed |
| WO-2023125907-A1 | DEGRADATION OF BRUTON'S TYROSINE KINASE (BTK) BY CONJUGATION OF BTK INHIBITORS WITH E3 LIGASE LIGAND AND METHODS OF USE | BEIGENE, LTD. (KY) | 2023-07-06 | — | — | WO | disclosed |